Cantabio Pharmaceuticals Inc, based in East Palo Alto, CA, is a research-focused company dedicated to developing innovative disease modifying therapeutics for neurodegeneration and metabolic conditions. Their scientific approach involves reducing the harmful effects of biochemical stress and targeting intrinsically disordered proteins to prevent and slow the progression of diseases such as Alzheimer's and Parkinson's.
With a strategic integration of therapeutic focus, biophysics, and novel drug discovery technologies, Cantabio Pharmaceuticals aims to tackle the challenges posed by these debilitating conditions. Their work has been recognized by the World Economic Forum as a Top 10 World Changing Technology, and they have been awarded grants by The Michael J. Fox Foundation for their groundbreaking research. Through their commitment to drug discovery and research, Cantabio Pharmaceuticals strives to make a significant impact in the field of healthcare.
Generated from the website